e-learning
resources
ERJ
2007
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Diaphragm dysfunction in chronic obstructive pulmonary disease: a role for heparan sulphate?
Ottenheijm C. A. C., Jenniskens G. J., Geraedts M. C. P., Hafmans T., Heunks L. M. A., van Kuppevelt T. H., Dekhuijzen P. N. R.
Source:
Eur Respir J 2007; 30: 80-89
Journal Issue:
July
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Ottenheijm C. A. C., Jenniskens G. J., Geraedts M. C. P., Hafmans T., Heunks L. M. A., van Kuppevelt T. H., Dekhuijzen P. N. R.. Diaphragm dysfunction in chronic obstructive pulmonary disease: a role for heparan sulphate?. Eur Respir J 2007; 30: 80-89
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
The physiology of breathlessness
Related content which might interest you:
Age-dependent elastin degradation is enhanced in chronic obstructive pulmonary disease
Source: Eur Respir J 2016; 48: 1215-1218
Year: 2016
Characterization of elastin degradation biomarkers in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Year: 2008
Age-dependent systemic elastin degradation is enhanced in chronic obstructive pulmonary disease
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Chronic obstructive pulmonary disease
Source: Eur Respir Monogr 2015; 70: 80-98
Year: 2015
Chronic obstructive pulmonary disease
Source: Eur Respir Monogr 2013; 62: 1-18
Year: 2013
Chronic obstructive pulmonary disease
Source: Eur Respir Mon; 2009: 45: 25–31
Year: 2009
Chronic obstructive pulmonary disease
Source: Eur Respir Monogr 2014; 65: 1-17
Year: 2014
Role of soluble α-klotho on lung and skeletal muscle function in chronic obstructive pulmonary disease
Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities
Year: 2016
Acute effect of oral steroids on muscle function in chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: 137-142
Year: 2004
Pulmonary endothelial dysfunction in chronic obstructive pulmonary disease
Source: ERS Research Seminar 2016 - Pulmonary Vascular Endothelium: Orchestra Conductor in Respiratory Diseases - Highlights from Basic Research to Therapy
Year: 2016
What is new in chronic obstructive pulmonary disease?
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=153
Year: 2007
Endothelial interactions of neutrophils under flow in chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 25: 612-617
Year: 2005
Chronic obstructive pulmonary disease and cardiac remodeling: gender aspect.
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018
Limitation to muscular activity in chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: 6-7
Year: 2004
Erythropoietin dysregulation in chronic obstructive pulmonary disease
Source: Annual Congress 2008 - COPD
Year: 2008
Elastin expression in very severe human COPD
Source: Eur Respir J 2009; 33: 324-331
Year: 2009
Efficiency of nebulised magnesium sulphate in exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 214s
Year: 2006
Unrecognised ventricular dysfunction in COPD
Source: Eur Respir J 2012; 39: 51-58
Year: 2012
Unrecognised ventricular dysfunction in COPD
Source: Eur Respir J 2011; 39: 51-58
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept